Viewing Study NCT00003532


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-01 @ 7:21 PM
Study NCT ID: NCT00003532
Status: TERMINATED
Last Update Posted: 2017-12-12
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Sponsor: Burzynski Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module